1.47 USD
356.85 M USD
1.67 B USD
About Orion Oyj Class A
Sector
Industry
CEO
Aino Anna Liisa Hurme
Website
Headquarters
Espoo
Founded
1917
ISIN
US68628Y1047
FIGI
BBG000WB0DP3
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
Related stocks
ORION misses investor expectations: Q4 EBITDA -31.3%FUNDAMENTAL:
The company improves EBITDA YoY +9.0% but misses Q4's by -31.3%.
Net Sales (YoY) +2.6% but missed Q4 -7.0%
Outlook for 2021:
Net sales in 2021 slightly lower than in 2020.
Operating profit estimated to be lower or clearly lower than in 2020.
TECHNICAL:
Fibonacci Retracement level sugge
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.